Recommendation: HOLD · Rating 6.2/10
SNCI11 é a tese middle-risk linearizada: distribuição mensal previsível de R$ 1,00 (DY 13,1% sobre cota a mercado), portfólio diversificado em 50 ativos (41 CRIs + 6 FIIs), com mandato explícito de capturar maior carrego em troca de aceitar workouts ocasionais. Para o investidor que já entendeu que todo FII de papel não-HG vai passar por eventos de crédito ao longo do ciclo, o SNCI oferece transparência alta sobre cada um deles.
Yield All-In da carteira de CRIs (MTM) é 17,56% a.a. — o gap para o DY ao cotista (13,1%) é absorvido por: taxa de gestão+administração (0,85% PL), provisões/marcação a custo dos workouts (~6,91% PL) e o yield mais baixo da parcela em FIIs. Com a alavancagem zerada em abr/26, o custo de dívida deixou de pesar. Quando os workouts maturarem (2S/26), parte desse gap pode reverter para distribuição ou VP.
O ponto-chave: o fundo manteve R$ 1,00 de DPS durante TODO o estresse de 2024-2025, com cota patrimonial em torno de R$ 97. Isso é resiliência — ainda mais com guidance R$ 1,00-1,10 mantido para o 2T/26.
SNCI holds 4 assets under special treatment as of Jun/2026 (totaling 6.91% of NAV):
The group represents direct asset risk to the unit, but the balance is decreasing, and marking at cost already reflects a conservative stance.
SNCI11 acquired R$ 24M in Gafisa S.A. shares (not CRIs) during the company's capital increase, with the sole declared objective of providing liquidity to complete the We Sorocaba development (Gafisa Sorocaba CRI in workout). About 60% has already been sold without losses within a structured operation; a remaining balance of ~R$ 9.6M is scheduled to be sold in upcoming periods.
This is an unusual operation for a CRI FII — involving equity risk (liquidity of Gafisa shares on B3, stock volatility, execution risk in selling the remainder without losses). The ultimate goal is legitimate (completing the construction that secures the CRI), but the mechanism adds an unconventional layer of risk to the portfolio.
Unlike pure high-grade peers (KNCR11, PCIP11, BTCI11), SNCI11 explicitly states a middle-risk positioning: by rating, A1 19.9% + A2 15.5% + A3 32.4% + A4 9.0% + A5 1.9% + D 5.3% (CRIs in recovery) + FIIs 10.1% + reverse repos 8.2% + cash 4.0% (Apr/26 MR).
The manager's thesis: capture higher carry during stress periods, with sector diversification and controlled LTV (weighted LTV of 65.72%). This means more credit events expected across the cycle than in high-grade funds — investors must be comfortable with this style. The 2025 track record (4 CRIs in workout) is living proof of the profile.
10.1% of NAV in units of other FIIs (significant drop vs. ~17% at the beginning of 2025): SNME11 (Suno Multi-Strategy, ~5.9% of NAV — fund managed in-house, 3,731,239 units), TGAR11 (1.9% of NAV), INOI (0.9% of NAV), RECD11 (0.7% of NAV), VRTM11 (0.6% of NAV), ZAVC11 (0.1% of NAV).
Management argues that nearly all NAV is directly or indirectly in CRIs (including look-through of invested FIIs), and that SNME11 originated from SNCI itself. To avoid conflicts of interest, the management fee does NOT apply to the portion allocated to SNME11.
Even so, a paper fund with allocations in third-party hybrid/paper FIIs adds a layer of complexity and a SNCI-SNME-Suno relationship that requires monitoring.
62.5% of the portfolio is indexed to IPCA with a residual portion in INCC. During months of deflation, carry decreases materially, which can pressure distributions below R$ 1.00 — historically, management uses retained earnings reserves (R$ 0.34/unit accumulated as of Apr/26) to smooth payouts. This more robust reserve provides a larger buffer than in 2025.
Conversely, with persistent IPCA above 4-5%, cash generation can rise and open room for extraordinary distributions — but current guidance already assumes R$ 1.00-1.10 without aggressive upside. The falling Selic rate (14.50%, 2 cuts) compresses the carry of CDI-linked CRIs (19.7% of NAV).
Book value per unit fluctuated between R$ 96.52 and R$ 98.85 over the last 12 months, closing Apr/26 at R$ 96.82 (a 0.42% monthly decline adjusted for distributions, in line with peers at -0.34%), pressured by the opening of the yield curve (MTM of CRIs) and declining portfolio FIIs. The fund distributes nearly all financial earnings monthly, so asset growth comes primarily from the mark-to-market of CRIs and workout recoveries.
The good news is that the recovery of troubled credits (marked at cost) tends to unlock book value as operations mature throughout H2/26.
Our current reading of SNCI11 is HOLD, with a score of 6.2/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
Sixth: R$ 1.00/unit guidance maintained for 16 months and zero leverage, but 4 CRIs in simultaneous recovery (6.91% of NAV), atypical purchase of Gafisa shares (R$ 24M) unusual for a CRI FII, and 10.1% of NAV allocated to other FIIs dilute the paper thesis.
Safety in a REIT is not yes or no — it is how much risk you accept. SNCI11 has a medio risk profile. What that means in practice:
| Component | Level |
|---|---|
| Concentração | 2.5 |
| Price volatility | 3.0 |
| Dividend volatility | 2.0 |
| Liquidez | 3.8 |
| Underlying asset risk | 4.0 |
| Financial/leverage risk | 3.0 |
The apparent top-1 holding is Supreme Garden (7.3%), but SPE BIT in Barueri has 4 series (BIT, Series 2, Series 3, Series 4) totaling approximately 7.3% of net assets in the SAME development. Same construction risk, same SPE, same Habitasec as the securitization agent. If trouble arises, all 4 series feel it together.
The same applies to SPE MZM (4 series, ~10.3% of net assets in the same development). Actual obligor risk is higher than the "top-1" figure implies.
SNME11 é fundo da própria Suno Asset. Se SNME entrar em ciclo de baixa cota (P/VP < 0,80) e SNCI precisar levantar caixa para distribuição/recompra de compromissadas, pode haver pressão de venda exatamente quando o preço estiver pior — risco de 'fire sale' em fundo da casa.
Mitigação: gestora declara explicitamente que NÃO faz desinvestimento forçado a menor que custo (RG fev/26 p. 22). Mas a regra não é contratual.
The manager chose to use held-to-maturity (HTM) pricing rather than mark-to-market (MTM) for the AIZ CRIs because mark-to-market accounting "created a distortion" (management report p. 30). This is a defensible technical decision — CRIs in workout carry off-market marks — but investors should note that the weighted portfolio yield (17.56%) includes this minor distortion from the AIZ CRI (1.56% of net assets).
In scale, it is immaterial. In terms of transparency, it is worth noting.
The RDR Itu CRI (4.7% of net assets) is the largest workout. The manager projects a 96.5% recovery over cost, factoring in R$ 10.6M in receivables + R$ 8M in inventory + R$ 1.5M in an escrow account.
Pessimistic scenario: if inventory sales take longer than 12 months, or if the receivables portfolio suffers additional delinquencies, actual recovery could drop to 70-80% of cost — resulting in a R$ 4-6M loss (~R$ 1/unit annually).
This is not a thesis-breaking scenario, but it is the most relevant asset risk today.
19.7% of the portfolio's net assets are in CDI-linked assets (average yield ~CDI + 5.52%). When the CDI rate falls (Selic is already at 14.50% in a rate-cut cycle), the yield on these CRIs drops alongside it, reducing nominal cash generation for this slice.
Mitigants: 62.5% of net assets are in IPCA+ (real carry preserved), leverage has been brought to zero (no debt servicing costs tied to the CDI), and the R$ 0.34/unit reserve cushions weak months. The net effect on the R$ 1.00 DPU is expected to be marginal within the guidance horizon.
| Scenario | Description |
|---|---|
| favoravel | RDR Itu recovers 95%+, AIZ exits its haircut as projected, Vanguarda achieves 80% via legal proceedings. Market price moves to R$ 95-98 (P/BV 0.97). Dividend yield compresses to 12.5% (compression on a higher unit price), but book value increases by R$ 0.30/unit. |
| favoravel | Selic drops from 14.75% to 12.5% (expected by Dec/26), compressing real interest rates. IPCA+ CRIs are marked upward. Unit prices could rise to R$ 96-100 even without resolving workouts. Risk: sharper Selic cuts put pressure on the portfolio's CDI yield. |
| desfavoravel | Multi-strategy mandate + 29% A4 imply a non-negligible probability of a new event. Potential candidates: Wimo CRIs (75% delinquency), Gafisa Sorocaba CRI (borrower with low liquidity), BIT CRI (construction at 66%). Impact: additional -1 to -3% of net assets. |
| desfavoravel | If inventory sales + receivables collection for RDR take longer than 18 months, or if there is additional portfolio delinquency, recovery falls to 70-80%. Direct impact: -R$ 4 to 6M in net assets = -R$ 0.9 to 1.4/unit. DPU could be squeezed to R$ 0.95-0.98 for 2-3 months. |
| favoravel | Average IPCA + 11.72% carry on 62% of net assets generates a larger reserve. DPU could rise to R$ 1.05-1.10. Unlikely given Suno's own IPCA guidance of 4.0% |
| ambivalente | Optimistic scenario (12% by Dec/26) — FII prices rise (benefiting SNCI), but the portfolio's CDI yield falls. The spread over leverage costs is maintained. Net effect: positive for unit price, neutral for DPU. |
SNCI11 enters Jun/2026 with its thesis partially validated: 15 consecutive months of a R$ 1.00 DPU, an adjusted performance of 21.26% over the last 6 months (vs. IFIX's 9.36%), zeroed leverage, and a P/BV recovered from 0.82 (Sep/25) to a peak of 0.94 in Apr/26 (pulling back to ~0.91 with the unit price at R$ 87.85). The fund navigated its first major credit stress event without cutting its dividend — a notable achievement for a middle-risk FII.
The key takeaway for the investor: the discount to book value exists because 6.91% of NAV is in workout (RDR CRI + AIZ + Vanguarda + Solar Junior). The question is not 'will the workouts be resolved?' — some will, others may disappoint. The question is 'has the manager demonstrated that it can maintain the DPU despite this?' — and the answer is yes. The 15 months at R$ 1.00 occurred during the stress, not after it.
Compared to peers: KNCR11/BTCI11/PCIP11 (P/BV ~0.97) offer lower workout risk in exchange for a 5 pp premium. RBRY11/VCJR11 (P/BV ~0.95) are similar middle-risk funds but feature performance fees. SNCI11 strikes a balance: middle-risk, no performance fee, P/BV of 0.91, and a dividend yield of 13.1%.
The manager, Suno Asset, has demonstrated the technical capacity to originate assets (CRI BIT Series 4 at CDI+5.50%, CRI MZM V at IPCA+12.95%, CRI LocPay at 23.87%) and manage workouts (AGT MZM on 26/02 extending 4 series, AGT AIZ approving a haircut while maintaining collateral, and recovering credits in RDR Itu). The SNCI-SNME relationship (5.9% of NAV in the manager's own vehicle) is a governance weakness, but the mitigation (zero fee on this portion) is appropriate.
For portfolio construction, SNCI11 functions as a middle-risk holding within a diversified paper FII portfolio — alongside a larger position in high-grade assets (PCIP/KNCR) and perhaps a pure pulverized vehicle (MXRF). It does not work as a sole paper/CRI position due to the level of risk assumed. With a P/BV of 0.91 and a dividend yield of 13.1%, it represents an entry point at a reasonable discount to book value — though not as cheap as in Sep/25 (P/BV 0.82).
Current recommendation: HOLD. Rating 6.2/10. Caution: 7% of assets are in 4 troubled loans (undergoing active recovery) — this is the primary risk and the reason for the unit discount. SNCI11 lends money to real estate developers, construction firms, and energy companies through CRIs (Brazilian real-estate receivables…
Our current read on SNCI11 is “HOLD”. Rating 6.2/10. Assess it against your risk profile and the points of attention listed above.
The main points of attention for Suno Recebíveis Imobiliários include: 4 CRIs in simultaneous recovery (6.91% of NAV); Atypical purchase of Gafisa S.A. shares (R$ 24M) — unusual equity exposure for a CRI FII; Middle-risk multi-strategy mandate (not high-grade) — recurring credit events; 10.1% of NAV invested in other FIIs (including SNME11 ~5.9% of NAV).
SNCI11 is suitable for: Investors seeking predictable monthly income of R$ 1.00 with a ~13% dividend yield who accept the trade-off of occasional workouts Those seeking exposure to diversified middle-risk CRIs who do not want to be held hostage by pure high-grade funds (KNCR/PCIP) Those who value the manager's transparency (Suno publishes extensive monthly…